|
DE2623228C3
(de)
|
1976-05-24 |
1981-09-10 |
Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren |
N-Acyl-substituierte Benzamide, Verfahren zu ihrer Herstellung und Arzneimittel, enthaltend solche Benzamide
|
|
JPS5587771A
(en)
|
1978-12-27 |
1980-07-02 |
Teikoku Hormone Mfg Co Ltd |
1-phenylisoquinoline derivative
|
|
US4456757A
(en)
|
1981-03-20 |
1984-06-26 |
Asahi Kasei Kogyo Kabushiki Kaisha |
Isoquinolinesulfonyl derivatives and process for the preparation thereof
|
|
JPS5993054A
(ja)
|
1982-11-18 |
1984-05-29 |
Asahi Chem Ind Co Ltd |
イソキノリンスルホン酸アミド誘導体
|
|
DK8386A
(da)
|
1986-01-15 |
1987-07-09 |
Tpo Pharmachim |
Nye n-substituerede 1-benzyl-2-carbamoyltetrahydroisoquinoliner og fremgangsmaade til fremstilling af samme
|
|
AU600992B2
(en)
|
1986-10-28 |
1990-08-30 |
Smith Kline & French Laboratories Limited |
Tetrahydroisoquinolin-2-yl derivatives of carboxylic acids
|
|
US4911928A
(en)
|
1987-03-13 |
1990-03-27 |
Micro-Pak, Inc. |
Paucilamellar lipid vesicles
|
|
US5591887A
(en)
|
1987-04-30 |
1997-01-07 |
R-Tech Ueno, Ltd. |
Prostaglandins of the F series
|
|
JPH01139528A
(ja)
|
1987-11-24 |
1989-06-01 |
Showa Denko Kk |
抗潰瘍剤
|
|
WO1990002553A1
(en)
|
1988-09-06 |
1990-03-22 |
Pharmacia Ab |
Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
|
|
DK0389995T3
(da)
|
1989-03-28 |
1995-07-03 |
Nisshin Flour Milling Co |
Isoquinolinderivater til behandling af glaukom eller okular hypertension
|
|
KR920008026A
(ko)
|
1990-10-24 |
1992-05-27 |
오노 화아마슈티칼 캄파니 리미팃드 |
이소퀴놀리논 유도체 또는 이의 무독성 산부가염 또는 이의 수화물, 이의 제조방법 및 이를 포함하는 약제 조성물
|
|
US5508288A
(en)
|
1992-03-12 |
1996-04-16 |
Smithkline Beecham, P.L.C. |
Indole derivatives as 5HT1C antagonists
|
|
US5972991A
(en)
|
1992-09-21 |
1999-10-26 |
Allergan |
Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
DE4332168A1
(de)
|
1993-02-22 |
1995-03-23 |
Thomae Gmbh Dr K |
Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US5510383A
(en)
|
1993-08-03 |
1996-04-23 |
Alcon Laboratories, Inc. |
Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
|
|
US6124344A
(en)
|
1993-12-28 |
2000-09-26 |
Allergan Sales, Inc. |
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
US5462968A
(en)
|
1994-01-19 |
1995-10-31 |
Allergan, Inc. |
EP2 -receptor agonists as agents for lowering intraocular pressure
|
|
US5698733A
(en)
|
1994-09-30 |
1997-12-16 |
Alcon Laboratories, Inc. |
Use of 9-deoxy prostaglandin derivatives to treat glaucoma
|
|
WO1998021180A1
(en)
|
1995-06-07 |
1998-05-22 |
Alcon Laboratories, Inc. |
Conformationally rigid aryl- or heteroaryl prostaglandins for use in glaucoma therapy
|
|
DE69633136T2
(de)
|
1995-12-22 |
2005-09-01 |
Alcon Laboratories, Inc., Fort Worth |
Substituierte tetrahydrofuran-analoge von prostaglandinen als augendrucksenkende mittel
|
|
US5866602A
(en)
|
1995-12-22 |
1999-02-02 |
Alcon Laboratories, Inc. |
Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
|
|
US5814660A
(en)
|
1995-12-22 |
1998-09-29 |
Alcon Laboratories, Inc. |
9-oxa prostaglandin analogs as ocular hypotensives
|
|
US6586425B2
(en)
|
1996-02-21 |
2003-07-01 |
Wisconsin Alumni Research Foundation |
Cytoskeletal active agents for glaucoma therapy
|
|
US5798380A
(en)
|
1996-02-21 |
1998-08-25 |
Wisconsin Alumni Research Foundation |
Cytoskeletal active agents for glaucoma therapy
|
|
ATE221048T1
(de)
|
1996-09-17 |
2002-08-15 |
Asahi Glass Co Ltd |
Fluorierte prostaglandinderivate und medikamente
|
|
AU5258698A
(en)
|
1996-11-12 |
1998-06-03 |
Alcon Laboratories, Inc. |
15-ketal prostaglandins for the treatment of glaucoma or ocular hypertension
|
|
US6353000B1
(en)
|
1996-11-12 |
2002-03-05 |
Alcon Laboratories, Inc. |
11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
|
|
JP2001504122A
(ja)
|
1996-11-12 |
2001-03-27 |
アルコン ラボラトリーズ，インコーポレイテッド |
眼圧降下剤としてのプロスタグランジン類のｃｉｓ―δ▲上４▼アナログ
|
|
ES2159889T3
(es)
|
1996-11-12 |
2001-10-16 |
Alcon Lab Inc |
15-fluoro prostaglandinas utilizadas como hipotensores oculares.
|
|
US6172109B1
(en)
|
1997-03-07 |
2001-01-09 |
Alcon Laboratories, Inc. |
13-Thia prostaglandins for use in glaucoma therapy
|
|
WO1998050024A1
(en)
|
1997-05-09 |
1998-11-12 |
The Mount Sinai School Of Medicine Of The City University Of New York |
8-iso-prostaglandins for glaucoma therapy
|
|
US5891646A
(en)
|
1997-06-05 |
1999-04-06 |
Duke University |
Methods of assaying receptor activity and constructs useful in such methods
|
|
SE9702706D0
(sv)
|
1997-07-11 |
1997-07-11 |
Pharmacia & Upjohn Ab |
Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
|
|
WO2000077027A2
(en)
|
1999-06-14 |
2000-12-21 |
Tularik Limited |
Serine protease inhibitors
|
|
EP1021402B1
(en)
|
1997-09-09 |
2005-11-23 |
Duke University |
Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
|
|
JP4619531B2
(ja)
|
1997-09-09 |
2011-01-26 |
デューク ユニバーシティ |
Ｆｐアゴニストとして有用な、芳香族のあるｃ１６〜ｃ２０が置換されたテトラヒドロプロスタグランジン類
|
|
AU731153B2
(en)
|
1997-09-09 |
2001-03-22 |
Duke University |
Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists
|
|
US5877211A
(en)
|
1997-11-21 |
1999-03-02 |
Allergan |
EP2 receptor agonists as neuroprotective agents for the eye
|
|
AU1709699A
(en)
|
1997-12-22 |
1999-07-12 |
Alcon Laboratories, Inc. |
13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
|
|
BR9906597A
(pt)
|
1998-07-14 |
2000-07-18 |
Alcon Lab Inc |
Produto de prostaglandina
|
|
TWI249520B
(en)
|
1998-07-15 |
2006-02-21 |
Ono Pharmaceutical Co |
5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient
|
|
US6720175B1
(en)
|
1998-08-18 |
2004-04-13 |
The Johns Hopkins University School Of Medicine |
Nucleic acid molecule encoding homer 1B protein
|
|
US20020065296A1
(en)
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
|
CA2374947A1
(en)
|
1999-05-24 |
2000-11-30 |
Robert M. Scarborough |
Inhibitors of factor xa
|
|
SI1249233T1
(sl)
|
1999-11-26 |
2009-02-28 |
Shionogi & Co |
Antagonisti NPYY5
|
|
US6787534B2
(en)
|
1999-12-28 |
2004-09-07 |
Eisai Co., Ltd. |
Sulfonamide-containing heterocyclic compounds
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
MXPA02007249A
(es)
|
2000-02-03 |
2002-12-09 |
Eisai Co Ltd |
Inhibidor de la expresion de integrina.
|
|
US6410566B1
(en)
|
2000-05-16 |
2002-06-25 |
Teijin Limited |
Cyclic amine derivatives and their use as drugs
|
|
US6908741B1
(en)
|
2000-05-30 |
2005-06-21 |
Transtech Pharma, Inc. |
Methods to identify compounds that modulate RAGE
|
|
US6855690B2
(en)
|
2000-06-01 |
2005-02-15 |
Children's Medical Center Corporation |
Methods and compositions for treating ocular disorders
|
|
US6323228B1
(en)
|
2000-09-15 |
2001-11-27 |
Abbott Laboratories |
3-substituted indole angiogenesis inhibitors
|
|
AU1401902A
(en)
|
2000-10-17 |
2002-04-29 |
Applied Research Systems |
Pharmaceutically active sulfanilide derivatives
|
|
US7163800B2
(en)
|
2000-11-03 |
2007-01-16 |
Molecular Devices Corporation |
Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity
|
|
CN1235583C
(zh)
|
2001-03-05 |
2006-01-11 |
特兰斯泰克制药公司 |
用作治疗剂的苯并咪唑衍生物
|
|
EP1379505B1
(en)
|
2001-04-20 |
2007-02-28 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
US6956035B2
(en)
|
2001-08-31 |
2005-10-18 |
Inotek Pharmaceuticals Corporation |
Isoquinoline derivatives and methods of use thereof
|
|
JP4505228B2
(ja)
|
2002-01-10 |
2010-07-21 |
バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト |
Ｒｈｏ−キナーゼ阻害剤
|
|
TW200306819A
(en)
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
AU2003245773A1
(en)
|
2002-02-15 |
2003-09-04 |
Glaxo Group Limited |
Vanilloid receptor modulators
|
|
WO2003073999A2
(en)
|
2002-03-01 |
2003-09-12 |
Pintex Pharmaceuticals, Inc. |
Pini-modulating compounds and methods of use thereof
|
|
DK1482931T3
(da)
|
2002-03-05 |
2011-12-19 |
Transtech Pharma Inc |
Mono- og bicycliske azolderivater der inhiberer interaktionen af ligander med RAGE
|
|
US7645878B2
(en)
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
|
GB0206876D0
(en)
|
2002-03-22 |
2002-05-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
CA2483692A1
(en)
|
2002-05-13 |
2003-11-27 |
Molecular Devices Corporation |
Constitutively translocating cell line
|
|
AU2003257588A1
(en)
|
2002-08-29 |
2004-03-19 |
Santen Pharmaceutical Co., Ltd. |
REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS
|
|
WO2004022753A1
(ja)
|
2002-08-30 |
2004-03-18 |
Anges Mg, Inc. |
アクチン関連新規細胞骨格タンパク質ｌａｃｓ
|
|
AU2003264427A1
(en)
|
2002-09-12 |
2004-04-30 |
Kirin Beer Kabushiki Kaisha |
Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
|
|
AU2003285952A1
(en)
*
|
2002-10-21 |
2004-05-13 |
Irm Llc |
Pyrrolidones with anti-hiv activity
|
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
|
US7585878B2
(en)
|
2003-06-12 |
2009-09-08 |
Astellas Pharma Inc. |
Benzamide derivative or salt thereof
|
|
EP1663204B1
(en)
|
2003-08-29 |
2014-05-07 |
Exelixis, Inc. |
C-kit modulators and methods of use
|
|
JP2007507547A
(ja)
|
2003-10-06 |
2007-03-29 |
グラクソ グループ リミテッド |
キナーゼ阻害剤としての１，７−二置換アザベンゾイミダゾールの調製
|
|
JP2007008816A
(ja)
|
2003-10-15 |
2007-01-18 |
Ube Ind Ltd |
新規イソキノリン誘導体
|
|
DE10348023A1
(de)
|
2003-10-15 |
2005-05-19 |
Imtm Gmbh |
Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
|
|
EP1679308B1
(en)
|
2003-10-15 |
2013-07-24 |
Ube Industries, Ltd. |
Novel indazole derivative
|
|
SE0400284D0
(sv)
|
2004-02-10 |
2004-02-10 |
Astrazeneca Ab |
Novel compounds
|
|
JP2005227441A
(ja)
|
2004-02-12 |
2005-08-25 |
Konica Minolta Medical & Graphic Inc |
光熱写真画像形成材料
|
|
JP4857128B2
(ja)
|
2004-02-20 |
2012-01-18 |
グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー |
新規な化合物
|
|
US20080096238A1
(en)
|
2004-03-30 |
2008-04-24 |
Alcon, Inc. |
High throughput assay for human rho kinase activity with enhanced signal-to-noise ratio
|
|
DE102004017438A1
(de)
|
2004-04-08 |
2005-11-03 |
Bayer Healthcare Ag |
Hetaryloxy-substituierte Phenylaminopyrimidine
|
|
US7453002B2
(en)
|
2004-06-15 |
2008-11-18 |
Bristol-Myers Squibb Company |
Five-membered heterocycles useful as serine protease inhibitors
|
|
EP1756092A4
(en)
|
2004-06-17 |
2009-12-02 |
Smithkline Beecham Corp |
NEW INHIBITORS OF RHO-KINASEN
|
|
ES2535364T3
(es)
|
2004-06-18 |
2015-05-08 |
Tobii Ab |
Control ocular de aparato informático
|
|
DE602005020465D1
(de)
|
2004-08-26 |
2010-05-20 |
Pfizer |
Enantiomerenreine aminoheteroaryl-verbindungen als proteinkinasehemmer
|
|
WO2006041119A1
(ja)
|
2004-10-13 |
2006-04-20 |
Eisai R & D Management Co., Ltd. |
ヒドラジド誘導体
|
|
UY29198A1
(es)
|
2004-11-09 |
2006-05-31 |
Cancer Rec Tech Ltd |
Derivados sustituidos de quinazolinona y derivados sustituidos de quinazolina-2, 4-diona, composiciones conteniéndolos, procedimientos de preparación y aplicaciones
|
|
GB0425026D0
(en)
|
2004-11-12 |
2004-12-15 |
Biofocus Discovery Ltd |
Compounds which bind to the active site of protein kinase enzymes
|
|
US7741479B2
(en)
|
2004-12-07 |
2010-06-22 |
Locus Pharmaceuticals, Inc. |
Urea inhibitors of MAP kinases
|
|
EP1833832A1
(en)
|
2004-12-31 |
2007-09-19 |
GPC Biotech AG |
Napthyridine compounds as rock inhibitors
|
|
AU2006204724A1
(en)
|
2005-01-14 |
2006-07-20 |
Millennium Pharmaceuticals, Inc. |
Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
|
|
KR20090028846A
(ko)
|
2005-01-28 |
2009-03-19 |
아이알엠 엘엘씨 |
페닐-치환 피롤리돈
|
|
WO2006086562A2
(en)
|
2005-02-09 |
2006-08-17 |
Microbia, Inc. |
Phenylazetidinone derivatives
|
|
WO2006127203A2
(en)
|
2005-05-25 |
2006-11-30 |
Wyeth |
Methods of synthesizing 6-alkylaminoquinoline derivatives
|
|
US7470787B2
(en)
|
2005-07-11 |
2008-12-30 |
Aerie Pharmaceuticals, Inc. |
Isoquinoline compounds
|
|
WO2007008942A2
(en)
|
2005-07-11 |
2007-01-18 |
Aerie Pharmaceuticals, Inc. |
Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases
|
|
WO2007050783A2
(en)
|
2005-10-26 |
2007-05-03 |
Asahi Kasei Pharma Corporation |
Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
|
|
TW200738682A
(en)
|
2005-12-08 |
2007-10-16 |
Organon Nv |
Isoquinoline derivatives
|
|
MX2008008328A
(es)
|
2005-12-22 |
2008-09-15 |
Alcon Res Ltd |
(indazol-5-il)-pirazinas y (1,3-dihidro-indol-2-ona)-pirazinas para tratar enfermedades y condiciones mediadas con rho cinasa.
|
|
AR057252A1
(es)
|
2005-12-27 |
2007-11-21 |
Alcon Mfg Ltd |
Inhibicion de rho quinasa mediada por arni para el tratamiento de trastornos oculares
|
|
BRPI0620736A2
(pt)
|
2005-12-30 |
2011-12-20 |
Novartis Ag |
compostos orgánicos
|
|
DK1973910T3
(da)
|
2006-01-27 |
2013-08-12 |
Shanghai Hengrui Pharm Co Ltd |
Pyrrolo[3,2-c]pyridin-4-on-2-indolinon-proteinkinaseinhibitorer
|
|
JP5476559B2
(ja)
|
2006-02-10 |
2014-04-23 |
国立大学法人九州大学 |
リン酸化酵素の新規基質ポリペプチド
|
|
US7625927B2
(en)
|
2006-02-27 |
2009-12-01 |
Alcon Research, Ltd. |
Method of treating glaucoma
|
|
US20070287707A1
(en)
|
2006-02-28 |
2007-12-13 |
Arrington Mark P |
Phosphodiesterase 10 inhibitors
|
|
JP2007246466A
(ja)
|
2006-03-17 |
2007-09-27 |
Osaka Univ |
中枢神経損傷に対する嗅粘膜移植にＲｈｏキナーゼ阻害剤を用いた神経機能再建法
|
|
RU2008152065A
(ru)
|
2006-06-08 |
2010-07-20 |
Убе Индастриз, Лтд (Jp) |
Новое производное имидазола со спироциклической структурой в боковой цепи
|
|
AU2007275221A1
(en)
|
2006-07-20 |
2008-01-24 |
Allen J. Borchardt |
Benzothiophene inhibitors of RHO kinase
|
|
WO2008036459A2
(en)
|
2006-07-20 |
2008-03-27 |
Borchardt Allen J |
Inhibitors of rho kinase
|
|
BRPI0714782A2
(pt)
|
2006-07-31 |
2013-07-16 |
Senju Pharma Co |
preparaÇço lÍquida aquosa contendo composto de amida
|
|
ES2729424T3
(es)
|
2006-09-20 |
2019-11-04 |
Aerie Pharmaceuticals Inc |
Inhibidores de Rho cinasa
|
|
US20110039893A1
(en)
|
2006-10-11 |
2011-02-17 |
Takeda Pharmaceutical Company Limited |
Gsk-3beta inhibitor
|
|
US8949825B1
(en)
|
2006-10-17 |
2015-02-03 |
Manageiq, Inc. |
Enforcement of compliance policies in managed virtual systems
|
|
US20090036465A1
(en)
|
2006-10-18 |
2009-02-05 |
United Therapeutics Corporation |
Combination therapy for pulmonary arterial hypertension
|
|
WO2008049919A2
(en)
|
2006-10-26 |
2008-05-02 |
Devgen N.V. |
Rho kinase inhibitors
|
|
US8071779B2
(en)
|
2006-12-18 |
2011-12-06 |
Inspire Pharmaceuticals, Inc. |
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
|
WO2008079945A2
(en)
|
2006-12-20 |
2008-07-03 |
University Of South Florida |
Rock inhibitors and uses thereof
|
|
AR064420A1
(es)
|
2006-12-21 |
2009-04-01 |
Alcon Mfg Ltd |
Composiciones farmaceuticas oftalmicas que comprenden una cantidad efectiva de analogos de 6-aminoimidazo[1,2b]piridazinas, utiles para el tratamiento del glaucoma y/o controlar la presion intraocular normal o elevada(iop).
|
|
BRPI0720986A2
(pt)
|
2006-12-27 |
2014-03-11 |
Sanofi Aventis |
Derivados de isoquinolina e isoquinolinona substituídos
|
|
RU2468011C2
(ru)
|
2006-12-27 |
2012-11-27 |
Санофи-Авентис |
Замещенные циклоалкиламином производные изохинолина и изохинолинона
|
|
MX2009005964A
(es)
|
2006-12-27 |
2009-06-15 |
Sanofi Aventis |
Derivados de isoquinolina sustituidos con cicloalquilamina.
|
|
MY148902A
(en)
|
2006-12-27 |
2013-06-14 |
Sanofi Aventis |
Substituted isoquinolines and their use as rho-kinase inhibitors
|
|
PT2125744E
(pt)
|
2006-12-27 |
2011-07-01 |
Sanofi Aventis |
Derivados de isoquinolona e isoquinolinona substituídos com cicloalquilamina
|
|
NZ577980A
(en)
|
2006-12-27 |
2012-01-12 |
Sanofi Aventis |
Cycloalkylamine substituted isoquinolone derivatives
|
|
JP5421783B2
(ja)
|
2006-12-27 |
2014-02-19 |
サノフイ |
Ｒｈｏキナーゼ阻害剤としての置換イソキノロン及びイソキノリノン誘導体
|
|
US8455513B2
(en)
|
2007-01-10 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-aminoisoquinoline compounds
|
|
US8415372B2
(en)
|
2007-02-27 |
2013-04-09 |
Asahi Kasei Pharma Corporation |
Sulfonamide compound
|
|
US20100063282A1
(en)
|
2007-04-10 |
2010-03-11 |
Boehringer Ingelheim International Gmbh |
Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions, and Uses Thereof
|
|
WO2009006567A2
(en)
|
2007-07-05 |
2009-01-08 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as akt protein kinase inhibitors
|
|
SI2217572T1
(sl)
*
|
2007-11-16 |
2014-05-30 |
Vertex Pharmaceuticals Incorporated |
Izokinolinski modulatorji prenaĺ alcev z atp-vezavno kaseto
|
|
US8455514B2
(en)
|
2008-01-17 |
2013-06-04 |
Aerie Pharmaceuticals, Inc. |
6-and 7-amino isoquinoline compounds and methods for making and using the same
|
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
|
ES2572615T3
(es)
|
2008-08-15 |
2016-06-01 |
Nivalis Therapeutics, Inc. |
Nuevos inhibidores pirrólicos de S-nitrosoglutatión reductasa como agentes terapéuticos
|
|
EP3828172A1
(en)
*
|
2009-05-01 |
2021-06-02 |
Aerie Pharmaceuticals, Inc. |
Dual mechanism inhibitors for the treatment of disease
|
|
BRPI1011683B8
(pt)
|
2009-06-19 |
2021-05-25 |
D Western Therapeutics Inst Inc |
derivados de isoquinolina substituída, suas composições farmacêuticas e seus usos
|
|
WO2011085351A2
(en)
*
|
2010-01-11 |
2011-07-14 |
The Johns Hopkins University |
Method of treating kcnq related disorders
|
|
FR2961694B1
(fr)
|
2010-06-29 |
2013-01-25 |
Thea Lab |
Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
|
|
EP2663553B1
(en)
|
2010-09-01 |
2015-08-26 |
Ambit Biosciences Corporation |
Quinoline and isoquinoline derivatives for use as jak modulators
|
|
AU2011327785A1
(en)
|
2010-11-08 |
2013-03-07 |
Healor Ltd. |
Buffered ophthalmic compositions and methods of use thereof
|
|
ES2684351T3
(es)
|
2011-02-04 |
2018-10-02 |
Kowa Co., Ltd. |
Terapia farmacológica para prevenir o tratar glaucoma
|
|
JP2013035802A
(ja)
|
2011-08-10 |
2013-02-21 |
D Western Therapeutics Institute Inc |
緑内障又は高眼圧症の予防又は治療剤
|
|
EP2671883A1
(en)
|
2012-06-05 |
2013-12-11 |
Bioprojet |
New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands
|
|
JP2014019650A
(ja)
|
2012-07-13 |
2014-02-03 |
Santen Pharmaceut Co Ltd |
スルホンアミド化合物とタフルプロストの組み合わせ
|
|
BR112015001959A2
(pt)
*
|
2012-08-01 |
2017-07-04 |
Merck Sharp & Dohme |
composto, composição farmacêutica, métodos para melhorar os déficits cognitivos, para prevenir ou tratar déficits cognitivos distúrbios neurodegenerativos ou neuropsiquiátricos, para o tratamento ou prevenção de doenças inflamatórias e de dor neuropática, uso de um composto, e, processo para preparar um composto
|
|
CA2887598A1
(en)
*
|
2012-10-12 |
2014-04-17 |
Takeda Pharmaceutical Company Limited |
Cyclopropanamine compound and use thereof
|
|
ES2852377T3
(es)
|
2013-03-15 |
2021-09-13 |
Aerie Pharmaceuticals Inc |
Sales dimesilato de 4-(3-amino-1-(isoquinolin-6-ilamino)-1-oxopropan-2-il)bencilo, sus combinaciones con prostaglandinas y el uso de las mismas en el tratamiento de trastornos oculares
|
|
JP2017522324A
(ja)
|
2014-07-17 |
2017-08-10 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
新規ナフチリジン及びイソキノリンならびにｃｄｋ８／１９阻害剤としてのその使用
|
|
US10227343B2
(en)
|
2015-01-30 |
2019-03-12 |
Vanderbilt University |
Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
|
|
US9770466B2
(en)
|
2015-07-02 |
2017-09-26 |
Veloce Biopharma, Llc |
Ophthalmic composition and methods of use
|
|
US9643927B1
(en)
|
2015-11-17 |
2017-05-09 |
Aerie Pharmaceuticals, Inc. |
Process for the preparation of kinase inhibitors and intermediates thereof
|
|
EP3500251A4
(en)
|
2016-08-19 |
2020-04-08 |
Aerie Pharmaceuticals, Inc. |
BETA AMINO ISOCHINOLINYL AMIDE COMPOUNDS
|
|
KR102568079B1
(ko)
|
2016-08-31 |
2023-08-17 |
에어리 파마슈티컬즈, 인코포레이티드 |
안과용 조성물
|
|
AU2018243687C1
(en)
|
2017-03-31 |
2020-12-24 |
Alcon Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|
|
CN111936139B
(zh)
|
2018-03-30 |
2023-10-13 |
爱瑞制药公司 |
6-氨基异喹啉的单(酸)盐及其用途
|
|
CA3112391A1
(en)
*
|
2018-09-14 |
2020-03-19 |
Aerie Pharmaceuticals, Inc. |
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
|